FADS2 and neoplasm: Additionally, FADS2-related gene enrichment analysis and immune infiltration analysis provide evidence of FADS2's potential role in regulating tumor immunity and indicate FADS2 can serve as a potential prognostic and immunotherapeutic biomarker for patients with cancers.